TCG Crossover GP I, LLC

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

TCG Crossover GP I, LLC sits at the top of its group. 19 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (18 companies). Each entity in the chart links to its source.

Stakes it holds

TCG Crossover GP I, LLC has told the SEC it owns more than 5% of 18 companies, latest first (Schedules 13D and 13G).

• Abivax S.A.SCHEDULE 13G/A Apr 19, 2024 to Aug 14, 2026²
• Entrada Therapeutics, Inc.SCHEDULE 13G/A Nov 25, 2025 to Aug 14, 2026³
• Vistagen Therapeutics, Inc.SCHEDULE 13G/A Aug 14, 2026⁴
• Savara IncSCHEDULE 13G/A Jul 25, 2023 to Feb 17, 2026⁵
• Cogent Biosciences, Inc.SCHEDULE 13G/A Feb 14, 2023 to Nov 14, 2025⁶
• Upstream Bio, Inc.SCHEDULE 13G/A Feb 14, 2025 to Nov 14, 2025⁷
• Compass PathwaysSCHEDULE 13G/A Aug 28, 2023 to Aug 14, 2025⁸
• CG Oncology, Inc.SCHEDULE 13G/A Feb 9, 2024 to May 15, 2025⁹
• Jade Biosciences, Inc.SCHEDULE 13G/A Feb 9, 2024 to May 15, 2025¹⁰
• Tyra Biosciences, Inc.SCHEDULE 13G Mar 6, 2025¹¹
• AN2 Therapeutics, Inc.SCHEDULE 13G/A Jul 25, 2023 to Feb 14, 2025¹²
• KalVista Pharmaceuticals, Inc.SC 13D/A Jan 9, 2023 to Apr 1, 2024¹³
• CymaBay Therapeutics (United States)SC 13G/A Feb 14, 2023 to Feb 13, 2024¹⁴
• Taysha Gene Therapies, Inc.SC 13G/A Aug 25, 2023 to Feb 9, 2024¹⁵
• Tourmaline Bio, Inc.SC 13G Feb 9, 2024¹⁶
• Icosavax, Inc.SC 13G Jul 25, 2023¹⁷
• Silence TherapeuticsSC 13G/A Feb 14, 2023¹⁸
• Viridian Therapeutics, Inc.\DESC 13G/A Feb 14, 2023¹⁹